We carried out a side-by-side comparison of the effects of Human cord blood serum (HcbS)
versus embryonic PRP on Human Wharton's Jelly Stem Cells (hWMSC) and dermal …

Bone marrow mesenchymal stromal cells (BMMSCs) have been used as feeder support for
the ex vivo expansion of hematopoietic stem cells (HSCs) but have the limitations of painful …

Human mesenchymal stem cells (MSCs) are a promising candidate for cell-based
transplantation and regenerative medicine therapies. Thus in the present study Wharton's …

Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) hold great potential for
their therapeutic use in various clinical diseases. Many publications have reported on …

Background aims. Perinatal tissues are considered an attractive source of mesenchymal
stem/stromal cells (MSCs) and have unique characteristics depending on their origin. In this …

Background: Mesenchymal stem cells (MSCs) are highly preferred in clinical therapy for
repair and regeneration of diseased tissues for their multipotent properties. Conventionally …

Objective The diverse clinical applications for human mesenchymal stem cells (hM-SCs) in
cellular therapy and regenerative medicine warrant increased focus on developing …

In recent years, umbilical cord blood (UCB) has been widely used as an alternative source
to bone marrow (BM) for transplantation of hematopoietic stem and progenitor cells (HSPCs) …

Abstract Background Human Wharton's jelly–derived mesenchymal stromal cells (hWJSCs)
have gained considerable attention for their use in cell therapy. Many of these applications …

The co-infusion of mesenchymal stromal cells (MSCs) with hematopoietic stem cells could
improve the hematopoietic engraftment after cord blood transplant. Adult bone marrow is the …